|
Volumn 54, Issue , 1997, Pages 2-6
|
A comparative, randomized trial of UFT® and 5-fluorouracil in combination with cyclophosphamide and doxorubicin in the treatment of advanced breast cancer patients at the philippines general hospital
a a a a a a |
Author keywords
5 FU; Cyclophosphamide; Doxorubicin; Metastatic breast cancer; UFT
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
TEGAFUR;
UFT;
URACIL;
ADULT;
ADVANCED CANCER;
ALOPECIA;
ANEMIA;
ANOREXIA;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
FEMALE;
GASTROINTESTINAL TOXICITY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
METASTASIS;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PHILIPPINES;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STOMATITIS;
THROMBOCYTOPENIA;
VOMITING;
ADMINISTRATION, ORAL;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
DRUG COMBINATIONS;
FLUOROURACIL;
HUMANS;
MIDDLE AGED;
NEOPLASM METASTASIS;
TEGAFUR;
URACIL;
|
EID: 0031060209
PISSN: 00302414
EISSN: 14230232
Source Type: Journal
DOI: 10.1159/000227737 Document Type: Article |
Times cited : (14)
|
References (9)
|